Pervasis Therapeutics Raising $25 Million Published: Oct 21, 2008 Pervasis Therapeutics Inc., a Cambridge, Mass.-based developer of regenerative cell-based therapies and devices, is seeking to raise $25 million in Series C funding, according to VentureWire. Related links Private Equity Hub This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news